According to a report on the analysis of hereditary breast cancer-related genes in Japanese breast cancer patients, the percentage of patients with germline TP53 variants is 3.9%, which is small compared to 72.5% for germline BRCA1/2 variants11). This evidence concerns the gene BRCA1 and breast carcinoma.